Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
Endo International plc (NASDAQ: ENDP) announced today that members of management will present at the J.P. Morgan 2021 Global High Yield & Leveraged Finance Conference on Monday, March 1, 2021 at 9:15 ...
Endo International plc (NASDAQ: ENDP) today announced that its Board of Directors has appointed Jennifer M. Chao to serve as a director, effective immediately. Ms. Chao has also been appointed to...
Endo International plc (NASDAQ: ENDP) will announce its fourth-quarter and full-year 2020 financial results on February 25, 2021 after the market closes and members of its senior management team will ...
Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited has entered into definitive agreements with Radius Health, Inc. (NASDAQ: RDUS) to register,...
Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), has begun shipping the first authorized generic versions of Mallinckrodt's...
Endo International plc (NASDAQ: ENDP) announced today that members of management will present at the J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 2:50 p.m. EST. A live webcast...
Endo International plc (NASDAQ: ENDP) announced today that it completed the previously announced acquisition of BioSpecifics Technologies Corp., a commercial-stage biopharmaceutical company, for...
Endo International plc (NASDAQ: ENDP) announced today that the Company will participate in two investor conferences. Members of management will participate in the 2020 Bank of America Leveraged...
Endo International plc (Nasdaq: ENDP) ("Endo") today announced the expiration of the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR...
Endo International plc (NASDAQ: ENDP) today reported financial results for the third-quarter ended September 30, 2020. "Our third-quarter 2020 results reflect growth in our Branded Pharmaceuticals...
Endo International plc (NASDAQ: ENDP) today announced the initiation of several strategic actions to further optimize the Company's operations and increase overall efficiency. These actions are...
Endo International plc (Nasdaq: ENDP) ("Endo") today announced that Endo's wholly-owned indirect subsidiary, Beta Acquisition Corp. ("Merger Sub"), has commenced its previously announced tender offer ...
Paladin Labs Inc., a subsidiary of Endo International plc (NASDAQ: ENDP), announced today that Ontario, Quebec, Manitoba and Saskatchewan now cover the cost of Envarsus® PA for kidney and liver...
Endo International plc (NASDAQ: ENDP) today announced it has agreed to acquire all of the outstanding shares of BioSpecifics Technologies Corp. (NASDAQ: BSTC), a commercial-stage biopharmaceutical...
Endo International plc (NASDAQ:ENDP) today announced that data relevant to the use of Endo Aesthetics' Qwo™ (collagenase clostridium histolyticum-aaes) for the treatment of moderate to severe...
Endo International plc (NASDAQ: ENDP) will announce its third–quarter 2020 financial results on November 5, 2020 after the market closes and members of its senior management team will host a...
Endo International plc (NASDAQ: ENDP) today announced the release of its first Environmental, Social and Governance (ESG) report, titled 2019 Corporate Responsibility Report: Helping Everyone We...
Endo International plc (NASDAQ: ENDP) today announced that its subsidiary, Par Pharmaceutical, Inc. (Par), has begun shipping sapropterin dihydrochloride tablets, 100 mg, and powder for oral...
Endo International plc (NASDAQ: ENDP) today announced that its subsidiary, Par Sterile Products, LLC (Par Sterile) has entered into a non-exclusive agreement with Novavax, Inc. to provide fill-finish ...
Endo International plc (NASDAQ:ENDP) today announced that it will present data relevant to the use of Qwo™ (collagenase clostridium histolyticum-aaes) for the treatment of moderate to severe...
Endo International plc (NASDAQ: ENDP) announced today that it will participate in the Citi 15th Annual BioPharma Virtual Conference being held September 8-10, 2020. Members of management will host...
Endo International plc (the "Company") (NASDAQ: ENDP) announced today the expiration and final tender results of the previously announced cash tender offer (the "Offer") by its wholly owned...
Endo International plc (the "Company" or "Endo") (NASDAQ: ENDP) announced today that Endo Finance LLC ("Endo Finance"), a wholly-owned subsidiary of the Company, has commenced a cash tender offer for ...
Endo International plc (NASDAQ: ENDP) today reported financial results for the second quarter ended June 30, 2020. "I'm proud of what our team delivered in the second quarter. Our Branded...
Endo International plc (NASDAQ: ENDP) today announced that it has changed the time of its previously announced conference call in an attempt to reduce conflicts with other earnings calls. The Company ...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.